AI Funding Ophthalmology

NovaSight raises $8 million Series A financing to tackle vision disorders worldwide

Released on July 14, 2020

Israel-based startup specialising in AI vision care, NovaSight, has announced that it has finalised its round A financing totalling $8 million. […]

Read more
CE Mark Implantables Ophthalmology

Staar Surgical launches presbyopia correcting lens

Released on July 7, 2020

Staar Surgical (NSDQ:STAA) announced today that it received CE Mark approval for its EVO Viva presbyiopia-correcting implantable Collamer lens (ICL). Lake Forest, […]

Read more
MedTech Ophthalmology

VisionCare names new CEO

Released on July 6, 2020

Visual prosthetic device developer VisionCare announced today that Thomas Ruggia has been appointed as its new CEO, effective today. Saratoga, Calif.-based VisionCare’s previous […]

Read more
AR/VR Imaging Ophthalmology

Ocutrx 8K 3D Eye Surgery Imaging System Unveiled

Released on June 9, 2020

Ocutrx, an augmented reality (AR) start-up based in Irvine, California, is releasing an ophthalmology visualization system designed to make it easier […]

Read more
CE Mark MedTech Ophthalmology

SightGlass Vision nets European approval for eyeglasses to reduce childhood myopia progression

Released on June 3, 2020

SightGlass Vision received a CE mark allowing its first suite of lenses—for eyeglasses specially designed to slow the progression of nearsightedness […]

Read more
Drug-delivery MedTech Ophthalmology

Medtech company granted £225k to develop drug-releasing eye lens

Released on June 2, 2020

A medtech company developing a biodegradable intraocular lens that can release drugs directly into the eye has been awarded just over […]

Read more
Funding Ophthalmology

Atia Vision closes $20m Series D

Released on May 21, 2020

Shifamed spinout and intraocular lens maker Atia Vision announced today that it closed the second tranche of a $20 million Series D financing. Campbell, […]

Read more
Funding Ophthalmology Public Offering

Ocular Therapeutix commences public offering

Released on May 20, 2020

Ocular Therapeutix (NSDQ:OCUL) announced that it commenced an underwritten public offering of an undisclosed amount of its common stock. The Bedford, Mass.-based […]

Read more
Ophthalmology Public Offering

Second Sight closes $6.8m offering

Released on May 8, 2020

Second Sight Medical (NSDQ:EYES) announced that it closed an offering of its common stock worth approximately $6.8 million. The maker of visual […]

Read more
Implantables Ophthalmology Public Offering

Second Sight prices public offering

Released on May 1, 2020

Second Sight Medical (NSDQ:EYES) announced that it priced an underwritten public offering with expected gross proceeds reaching $7.5 million. The maker of […]

Read more
Implantables MedTech Ophthalmology

Second Sight Gives Clearer Picture of Strategy Going Forward

Released on April 28, 2020

Second Sight Medical Products provided an update on its strategic options and gave some clarity on a plan going forward. The […]

Read more
Implantables Ophthalmology

To build eye implants, developer looks 250 miles up

Released on April 14, 2020

To build a delicate, bioengineered eye implant capable of restoring a person’s vision, one company is setting their sights high—really high—by […]

Read more